Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New guidance for purchasers of HIV/AIDS medicines


An updated edition of Sources and Prices of Selected Medicines and Diagnostics for People living with HIV/AIDS will be released today. The report provides market information on 74 reviewed products for the treatment and management of HIV/AIDS from 61 manufacturers.

The report gives purchasers of AIDS medicines and diagnostics a range of choices related to suppliers and affordability. The medicines included were selected on the basis of WHO standard treatment guidelines. The list is not exhaustive but covers the most commonly used HIV/AIDS medicines, with paediatric forms included wherever possible.

Improving access to medicines for people living with HIV/AIDS is a challenge for all countries but especially for developing ones. By the end of 2002, UNAIDS estimated that 42 million people in the world were living with HIV/AIDS and that over 95% of these were in poor nations. Last year, 3.1 million people died of the disease, many of them because they had had no access to treatment.

While high prices constitute one of the main barriers to accessing treatment, a few recent initiatives have brought the price of certain medicines down. However, even where affordable alternatives exist, many decision-makers do not have the information they need to identify those manufacturers that can supply the medicines needed. Without such information, there is a risk that low-income countries pay more than necessary – and sometimes more than industrialized countries – to obtain essential medicines. The report helps fill that gap.

This report is the fourth in a series of annual publications of sources and prices surveys commenced in 1999 by United Nations Children’s Fund (UNICEF), UNAIDS, the World Health Organization (WHO) and Médecins Sans Frontières (MSF). The present edition is the result of a survey carried out from December 2002 through February 2003, of 388 manufacturers in 50 countries.

The report includes antiretroviral (ARV) medicines, medicines used to treat a range of opportunistic infections, medicines for use in palliative care, medicines for the treatment of HIV-related cancers and for the management of opioid dependence. It also provides information on a range of test kits for the diagnosis and monitoring of HIV/AIDS.

A new section has been added on the registration status of products in the survey. This information will be useful for people in countries who are in the process of granting market authorization to HIV/AIDS related products.

Finally, the latest edition of an MSF document, Untangling the Web of Price Reductions: a pricing guide for the purchase of ARVs for developing countries has been included as an annex to provide a comprehensive overview of the prices of ARV medicines offered by research-based pharmaceutical companies and some generics manufacturers in low- and middle-income countries.

Sources and Prices 2003 can be found on the following web sites: UNICEF, WHO, médecins sans frontières.

For more informations:

Ms Daniela Bagozzi
Telephone: +41 22 791 4544

Daniela Bagozzi | WHO
Further information:

More articles from Health and Medicine:

nachricht Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>